The articles listed on this page are from a variety of sources. 
1. The staff of DBS-STN often attends conferences or educational opportunities both nationally and internationally, and a brief understandable write-up of the information presented at the event will be provided for our readers to review. 
2. DBS-STN staff also identifies or writes various articles related to topics that are thought to be of interest for the reader of www.DBS-STN.org. 

Browse by Topic:
Search:

NeuroDerm Presents Results of Continuous Subcutaneous Administration of Levodopa/Carbidopa Trials


(October 29, 2014) - NeuroDerm Ltd. announced that top-line results for ND0612L from a phase II study in patients with moderate Parkinson's patients, and preliminary interim results from a phase IIA study of ND0612H and ND0612L in advanced Parkinson's patients, will be presented at The Michael J. Fox Foundation's 2014 Parkinson's Disease Therapeutics Conference, today in New York, NY.

This research, Continuous Subcutaneous Administration of Levodopa/Carbidopa (ND0612) for the Treatment of Parkinson's Disease, is partially funded with a grant from the Parkinson’s Unity Walk. Read more…



Article Archive

back